nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—HDAC2—hematologic cancer	0.201	0.667	CbGaD
Theophylline—ADA—Pentostatin—hematologic cancer	0.116	0.248	CbGbCtD
Theophylline—PDE4B—hematologic cancer	0.101	0.333	CbGaD
Theophylline—ADA—Nelarabine—hematologic cancer	0.0664	0.143	CbGbCtD
Theophylline—HDAC2—Vorinostat—hematologic cancer	0.0521	0.112	CbGbCtD
Theophylline—PDE3A—Anagrelide—hematologic cancer	0.0476	0.102	CbGbCtD
Theophylline—CYP1B1—Procarbazine—hematologic cancer	0.0207	0.0445	CbGbCtD
Theophylline—CYP1B1—Daunorubicin—hematologic cancer	0.0111	0.0239	CbGbCtD
Theophylline—CYP1B1—Dasatinib—hematologic cancer	0.00684	0.0147	CbGbCtD
Theophylline—CYP1B1—Mitoxantrone—hematologic cancer	0.00676	0.0145	CbGbCtD
Theophylline—CYP1A2—Anagrelide—hematologic cancer	0.00536	0.0115	CbGbCtD
Theophylline—CYP1A1—Methoxsalen—hematologic cancer	0.00536	0.0115	CbGbCtD
Theophylline—CYP1A1—Bortezomib—hematologic cancer	0.0051	0.011	CbGbCtD
Theophylline—CYP1A1—Daunorubicin—hematologic cancer	0.00488	0.0105	CbGbCtD
Theophylline—CYP1A1—Thalidomide—hematologic cancer	0.00444	0.00954	CbGbCtD
Theophylline—CYP1A1—Dacarbazine—hematologic cancer	0.00382	0.00821	CbGbCtD
Theophylline—CYP1B1—Dexamethasone—hematologic cancer	0.0035	0.00752	CbGbCtD
Theophylline—CYP2E1—Thalidomide—hematologic cancer	0.00343	0.00737	CbGbCtD
Theophylline—CYP2C9—Bexarotene—hematologic cancer	0.00335	0.00719	CbGbCtD
Theophylline—CYP1A1—Dasatinib—hematologic cancer	0.003	0.00645	CbGbCtD
Theophylline—CYP2E1—Dacarbazine—hematologic cancer	0.00295	0.00634	CbGbCtD
Theophylline—CYP2C8—Bortezomib—hematologic cancer	0.00294	0.00632	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—hematologic cancer	0.00291	0.00624	CbGbCtD
Theophylline—CYP2D6—Lomustine—hematologic cancer	0.00285	0.00612	CbGbCtD
Theophylline—CYP1A2—Carmustine—hematologic cancer	0.00282	0.00605	CbGbCtD
Theophylline—CYP2C9—Idarubicin—hematologic cancer	0.00278	0.00596	CbGbCtD
Theophylline—SLC22A7—Methotrexate—hematologic cancer	0.00255	0.00547	CbGbCtD
Theophylline—CYP2D6—Idarubicin—hematologic cancer	0.00254	0.00545	CbGbCtD
Theophylline—CYP1A2—Methoxsalen—hematologic cancer	0.0024	0.00515	CbGbCtD
Theophylline—CYP2E1—Mitoxantrone—hematologic cancer	0.00229	0.00492	CbGbCtD
Theophylline—CYP1A2—Bortezomib—hematologic cancer	0.00228	0.00489	CbGbCtD
Theophylline—CYP2C8—Ifosfamide—hematologic cancer	0.00226	0.00485	CbGbCtD
Theophylline—CYP1A2—Daunorubicin—hematologic cancer	0.00218	0.00468	CbGbCtD
Theophylline—CYP2D6—Hydroxyurea—hematologic cancer	0.00216	0.00464	CbGbCtD
Theophylline—CYP1A2—Alitretinoin—hematologic cancer	0.00214	0.00459	CbGbCtD
Theophylline—CYP2C9—Bortezomib—hematologic cancer	0.00205	0.00441	CbGbCtD
Theophylline—CYP1A2—Thalidomide—hematologic cancer	0.00199	0.00426	CbGbCtD
Theophylline—CYP2C8—Nilotinib—hematologic cancer	0.00196	0.00421	CbGbCtD
Theophylline—CYP3A4—Bexarotene—hematologic cancer	0.00195	0.00418	CbGbCtD
Theophylline—CYP2D6—Bortezomib—hematologic cancer	0.00188	0.00403	CbGbCtD
Theophylline—CYP3A4—Busulfan—hematologic cancer	0.00181	0.00389	CbGbCtD
Theophylline—CYP3A4—Lomustine—hematologic cancer	0.00181	0.00389	CbGbCtD
Theophylline—CYP2C9—Thalidomide—hematologic cancer	0.00179	0.00384	CbGbCtD
Theophylline—CYP1A2—Dacarbazine—hematologic cancer	0.00171	0.00367	CbGbCtD
Theophylline—CYP2C9—Teniposide—hematologic cancer	0.00171	0.00366	CbGbCtD
Theophylline—CYP1A2—Imatinib—hematologic cancer	0.00167	0.00359	CbGbCtD
Theophylline—CYP3A4—Thiotepa—hematologic cancer	0.00161	0.00347	CbGbCtD
Theophylline—CYP2C9—Ifosfamide—hematologic cancer	0.00157	0.00338	CbGbCtD
Theophylline—CYP1A1—Dexamethasone—hematologic cancer	0.00154	0.0033	CbGbCtD
Theophylline—CYP2C9—Imatinib—hematologic cancer	0.0015	0.00323	CbGbCtD
Theophylline—CYP2E1—Etoposide—hematologic cancer	0.00144	0.0031	CbGbCtD
Theophylline—CYP2D6—Imatinib—hematologic cancer	0.00138	0.00295	CbGbCtD
Theophylline—CYP2C9—Nilotinib—hematologic cancer	0.00137	0.00294	CbGbCtD
Theophylline—CYP1A2—Dasatinib—hematologic cancer	0.00134	0.00288	CbGbCtD
Theophylline—CYP3A4—Methoxsalen—hematologic cancer	0.00126	0.0027	CbGbCtD
Theophylline—CYP2D6—Nilotinib—hematologic cancer	0.00125	0.00268	CbGbCtD
Theophylline—PDE3B—hematopoietic system—hematologic cancer	0.00125	0.0345	CbGeAlD
Theophylline—CYP2D6—Vinorelbine—hematologic cancer	0.00124	0.00266	CbGbCtD
Theophylline—CYP3A4—Bortezomib—hematologic cancer	0.00119	0.00256	CbGbCtD
Theophylline—CYP2E1—Dexamethasone—hematologic cancer	0.00119	0.00255	CbGbCtD
Theophylline—CYP3A4—Daunorubicin—hematologic cancer	0.00114	0.00245	CbGbCtD
Theophylline—CYP2C8—Etoposide—hematologic cancer	0.00108	0.00232	CbGbCtD
Theophylline—CYP3A4—Cytarabine—hematologic cancer	0.00101	0.00216	CbGbCtD
Theophylline—CYP3A4—Teniposide—hematologic cancer	0.000992	0.00213	CbGbCtD
Theophylline—ADA—hematopoietic system—hematologic cancer	0.000946	0.0261	CbGeAlD
Theophylline—CYP3A4—Ifosfamide—hematologic cancer	0.000916	0.00197	CbGbCtD
Theophylline—CYP2C8—Dexamethasone—hematologic cancer	0.000887	0.00191	CbGbCtD
Theophylline—CYP3A4—Imatinib—hematologic cancer	0.000875	0.00188	CbGbCtD
Theophylline—ADORA2A—hematopoietic system—hematologic cancer	0.000861	0.0238	CbGeAlD
Theophylline—CYP1A2—Etoposide—hematologic cancer	0.000835	0.00179	CbGbCtD
Theophylline—PDE3B—blood—hematologic cancer	0.000827	0.0229	CbGeAlD
Theophylline—CYP3A4—Ruxolitinib—hematologic cancer	0.000824	0.00177	CbGbCtD
Theophylline—PDE3B—bone marrow—hematologic cancer	0.0008	0.0221	CbGeAlD
Theophylline—CYP3A4—Nilotinib—hematologic cancer	0.000795	0.00171	CbGbCtD
Theophylline—CYP3A4—Vinorelbine—hematologic cancer	0.000788	0.00169	CbGbCtD
Theophylline—PDE5A—hematopoietic system—hematologic cancer	0.000784	0.0217	CbGeAlD
Theophylline—Aminophylline—HDAC2—hematologic cancer	0.000774	0.208	CrCbGaD
Theophylline—CYP2C9—Cisplatin—hematologic cancer	0.000766	0.00165	CbGbCtD
Theophylline—CYP2D6—Vinblastine—hematologic cancer	0.000764	0.00164	CbGbCtD
Theophylline—PDE3A—hematopoietic system—hematologic cancer	0.000763	0.0211	CbGeAlD
Theophylline—ADORA1—hematopoietic system—hematologic cancer	0.000743	0.0205	CbGeAlD
Theophylline—HDAC2—hematopoietic system—hematologic cancer	0.000734	0.0203	CbGeAlD
Theophylline—PDE3B—lung—hematologic cancer	0.000725	0.02	CbGeAlD
Theophylline—CYP3A4—Triamcinolone—hematologic cancer	0.000721	0.00155	CbGbCtD
Theophylline—CYP3A4—Dasatinib—hematologic cancer	0.000703	0.00151	CbGbCtD
Theophylline—CYP3A4—Mitoxantrone—hematologic cancer	0.000694	0.00149	CbGbCtD
Theophylline—ADORA2B—blood—hematologic cancer	0.000685	0.0189	CbGeAlD
Theophylline—PDE3B—testis—hematologic cancer	0.000684	0.0189	CbGeAlD
Theophylline—ADORA2A—gonad—hematologic cancer	0.000654	0.0181	CbGeAlD
Theophylline—HDAC2—Topotecan—Irinotecan—hematologic cancer	0.000651	0.494	CbGdCrCtD
Theophylline—ADA—blood—hematologic cancer	0.000627	0.0173	CbGeAlD
Theophylline—CYP2C9—Dexamethasone—hematologic cancer	0.000619	0.00133	CbGbCtD
Theophylline—CYP3A4—Betamethasone—hematologic cancer	0.000619	0.00133	CbGbCtD
Theophylline—CYP3A4—Prednisolone—hematologic cancer	0.00061	0.00131	CbGbCtD
Theophylline—ADA—bone marrow—hematologic cancer	0.000606	0.0168	CbGeAlD
Theophylline—PDE4D—lung—hematologic cancer	0.000605	0.0167	CbGeAlD
Theophylline—ADORA2B—lung—hematologic cancer	0.000601	0.0166	CbGeAlD
Theophylline—PDE5A—gonad—hematologic cancer	0.000596	0.0165	CbGeAlD
Theophylline—CYP3A4—Prednisone—hematologic cancer	0.000576	0.00124	CbGbCtD
Theophylline—PDE4D—testis—hematologic cancer	0.000571	0.0158	CbGeAlD
Theophylline—ADORA2A—blood—hematologic cancer	0.00057	0.0158	CbGeAlD
Theophylline—ADORA2B—testis—hematologic cancer	0.000567	0.0157	CbGeAlD
Theophylline—CYP2D6—Dexamethasone—hematologic cancer	0.000566	0.00122	CbGbCtD
Theophylline—HDAC2—gonad—hematologic cancer	0.000558	0.0154	CbGeAlD
Theophylline—PDE4B—hematopoietic system—hematologic cancer	0.00055	0.0152	CbGeAlD
Theophylline—ADA—lung—hematologic cancer	0.000549	0.0152	CbGeAlD
Theophylline—CYP3A4—Irinotecan—hematologic cancer	0.000546	0.00117	CbGbCtD
Theophylline—PDE4A—lung—hematologic cancer	0.000535	0.0148	CbGeAlD
Theophylline—PDE5A—blood—hematologic cancer	0.000519	0.0144	CbGeAlD
Theophylline—ADA—testis—hematologic cancer	0.000518	0.0143	CbGeAlD
Theophylline—PDE4A—testis—hematologic cancer	0.000505	0.014	CbGeAlD
Theophylline—PDE3A—blood—hematologic cancer	0.000505	0.014	CbGeAlD
Theophylline—PDE3B—lymph node—hematologic cancer	0.000496	0.0137	CbGeAlD
Theophylline—HDAC2—blood—hematologic cancer	0.000486	0.0134	CbGeAlD
Theophylline—CYP3A4—Vinblastine—hematologic cancer	0.000486	0.00104	CbGbCtD
Theophylline—CYP3A4—Vincristine—hematologic cancer	0.000478	0.00103	CbGbCtD
Theophylline—ADORA2A—testis—hematologic cancer	0.000472	0.013	CbGeAlD
Theophylline—CYP1B1—hematopoietic system—hematologic cancer	0.000471	0.013	CbGeAlD
Theophylline—HDAC2—bone marrow—hematologic cancer	0.000471	0.013	CbGeAlD
Theophylline—CYP2D6—Doxorubicin—hematologic cancer	0.000469	0.00101	CbGbCtD
Theophylline—SLC22A7—testis—hematologic cancer	0.000467	0.0129	CbGeAlD
Theophylline—PDE5A—lung—hematologic cancer	0.000455	0.0126	CbGeAlD
Theophylline—Oxtriphylline—HDAC2—hematologic cancer	0.000445	0.12	CrCbGaD
Theophylline—PDE3A—lung—hematologic cancer	0.000443	0.0122	CbGeAlD
Theophylline—CYP3A4—Etoposide—hematologic cancer	0.000438	0.00094	CbGbCtD
Theophylline—ADORA1—lung—hematologic cancer	0.000432	0.0119	CbGeAlD
Theophylline—PDE5A—testis—hematologic cancer	0.00043	0.0119	CbGeAlD
Theophylline—HDAC2—lung—hematologic cancer	0.000426	0.0118	CbGeAlD
Theophylline—PDE4B—gonad—hematologic cancer	0.000418	0.0115	CbGeAlD
Theophylline—PDE3A—testis—hematologic cancer	0.000418	0.0115	CbGeAlD
Theophylline—PDE4D—lymph node—hematologic cancer	0.000414	0.0114	CbGeAlD
Theophylline—ADORA1—testis—hematologic cancer	0.000407	0.0113	CbGeAlD
Theophylline—HDAC2—testis—hematologic cancer	0.000402	0.0111	CbGeAlD
Theophylline—ADA—lymph node—hematologic cancer	0.000376	0.0104	CbGeAlD
Theophylline—HDAC2—Menadione—Thalidomide—hematologic cancer	0.000374	0.284	CbGdCrCtD
Theophylline—Enprofylline—PDE4B—hematologic cancer	0.000371	0.0999	CrCbGaD
Theophylline—PDE4A—lymph node—hematologic cancer	0.000366	0.0101	CbGeAlD
Theophylline—Caffeine—ATM—hematologic cancer	0.000366	0.0985	CrCbGaD
Theophylline—PDE4B—blood—hematologic cancer	0.000364	0.0101	CbGeAlD
Theophylline—CYP2C8—hematopoietic system—hematologic cancer	0.000361	0.00997	CbGeAlD
Theophylline—CYP3A4—Dexamethasone—hematologic cancer	0.00036	0.000773	CbGbCtD
Theophylline—CYP1B1—gonad—hematologic cancer	0.000358	0.0099	CbGeAlD
Theophylline—PDE4B—bone marrow—hematologic cancer	0.000352	0.00974	CbGeAlD
Theophylline—CYP1A2—hematopoietic system—hematologic cancer	0.000338	0.00933	CbGeAlD
Theophylline—Caffeine—PIK3CB—hematologic cancer	0.000335	0.0901	CrCbGaD
Theophylline—Caffeine—PIK3CD—hematologic cancer	0.000335	0.0901	CrCbGaD
Theophylline—CYP1A1—hematopoietic system—hematologic cancer	0.000333	0.0092	CbGeAlD
Theophylline—CYP2C9—hematopoietic system—hematologic cancer	0.00032	0.00886	CbGeAlD
Theophylline—PDE4B—lung—hematologic cancer	0.000319	0.00882	CbGeAlD
Theophylline—CYP1B1—blood—hematologic cancer	0.000312	0.00863	CbGeAlD
Theophylline—PDE5A—lymph node—hematologic cancer	0.000311	0.00861	CbGeAlD
Theophylline—CYP2E1—hematopoietic system—hematologic cancer	0.000304	0.00839	CbGeAlD
Theophylline—PDE3A—lymph node—hematologic cancer	0.000303	0.00837	CbGeAlD
Theophylline—PDE4B—testis—hematologic cancer	0.000301	0.00832	CbGeAlD
Theophylline—CYP3A4—Doxorubicin—hematologic cancer	0.000299	0.000641	CbGbCtD
Theophylline—ADORA1—lymph node—hematologic cancer	0.000295	0.00816	CbGeAlD
Theophylline—HDAC2—Teniposide—Etoposide—hematologic cancer	0.000293	0.223	CbGdCrCtD
Theophylline—HDAC2—lymph node—hematologic cancer	0.000292	0.00806	CbGeAlD
Theophylline—CYP1B1—lung—hematologic cancer	0.000274	0.00756	CbGeAlD
Theophylline—Caffeine—PIK3CA—hematologic cancer	0.000259	0.0697	CrCbGaD
Theophylline—CYP1B1—testis—hematologic cancer	0.000258	0.00713	CbGeAlD
Theophylline—Theobromine—PDE4B—hematologic cancer	0.000257	0.0692	CrCbGaD
Theophylline—CYP3A4—hematopoietic system—hematologic cancer	0.000244	0.00675	CbGeAlD
Theophylline—CYP2D6—hematopoietic system—hematologic cancer	0.00024	0.00665	CbGeAlD
Theophylline—CYP2C8—blood—hematologic cancer	0.000239	0.00661	CbGeAlD
Theophylline—CYP1A2—blood—hematologic cancer	0.000224	0.00618	CbGeAlD
Theophylline—Oxtriphylline—PDE4B—hematologic cancer	0.000222	0.0598	CrCbGaD
Theophylline—CYP1A1—blood—hematologic cancer	0.000221	0.0061	CbGeAlD
Theophylline—PDE4B—lymph node—hematologic cancer	0.000218	0.00603	CbGeAlD
Theophylline—CYP2C9—blood—hematologic cancer	0.000212	0.00587	CbGeAlD
Theophylline—CYP2E1—blood—hematologic cancer	0.000201	0.00556	CbGeAlD
Theophylline—CYP2C8—testis—hematologic cancer	0.000198	0.00546	CbGeAlD
Theophylline—CYP1A2—lung—hematologic cancer	0.000196	0.00542	CbGeAlD
Theophylline—CYP1A1—lung—hematologic cancer	0.000193	0.00535	CbGeAlD
Theophylline—Dyphylline—PDE4B—hematologic cancer	0.000189	0.0509	CrCbGaD
Theophylline—CYP1B1—lymph node—hematologic cancer	0.000187	0.00517	CbGeAlD
Theophylline—CYP2E1—lung—hematologic cancer	0.000176	0.00487	CbGeAlD
Theophylline—CYP2E1—testis—hematologic cancer	0.000166	0.0046	CbGeAlD
Theophylline—CYP3A4—blood—hematologic cancer	0.000162	0.00447	CbGeAlD
Theophylline—CYP2D6—blood—hematologic cancer	0.000159	0.0044	CbGeAlD
Theophylline—CYP1A1—lymph node—hematologic cancer	0.000132	0.00366	CbGeAlD
Theophylline—Caffeine—PDE4B—hematologic cancer	0.000132	0.0356	CrCbGaD
Theophylline—CYP2D6—testis—hematologic cancer	0.000132	0.00364	CbGeAlD
Theophylline—Caffeine—ABCB1—hematologic cancer	3.02e-05	0.00814	CrCbGaD
Theophylline—Diarrhoea—Alitretinoin—hematologic cancer	2.86e-05	0.00026	CcSEcCtD
Theophylline—Convulsion—Betamethasone—hematologic cancer	2.85e-05	0.000259	CcSEcCtD
Theophylline—Convulsion—Dexamethasone—hematologic cancer	2.85e-05	0.000259	CcSEcCtD
Theophylline—Headache—Thiotepa—hematologic cancer	2.84e-05	0.000259	CcSEcCtD
Theophylline—Decreased appetite—Etoposide—hematologic cancer	2.83e-05	0.000258	CcSEcCtD
Theophylline—Diarrhoea—Ifosfamide—hematologic cancer	2.82e-05	0.000257	CcSEcCtD
Theophylline—Nausea—Vinorelbine—hematologic cancer	2.82e-05	0.000257	CcSEcCtD
Theophylline—Body temperature increased—Cisplatin—hematologic cancer	2.81e-05	0.000256	CcSEcCtD
Theophylline—Vomiting—Thalidomide—hematologic cancer	2.79e-05	0.000254	CcSEcCtD
Theophylline—Anxiety—Dexamethasone—hematologic cancer	2.79e-05	0.000254	CcSEcCtD
Theophylline—Anxiety—Betamethasone—hematologic cancer	2.79e-05	0.000254	CcSEcCtD
Theophylline—Dizziness—Carmustine—hematologic cancer	2.79e-05	0.000253	CcSEcCtD
Theophylline—Rash—Thalidomide—hematologic cancer	2.77e-05	0.000252	CcSEcCtD
Theophylline—Dermatitis—Thalidomide—hematologic cancer	2.76e-05	0.000251	CcSEcCtD
Theophylline—Dizziness—Alitretinoin—hematologic cancer	2.76e-05	0.000251	CcSEcCtD
Theophylline—Diarrhoea—Vincristine—hematologic cancer	2.75e-05	0.00025	CcSEcCtD
Theophylline—Headache—Thalidomide—hematologic cancer	2.75e-05	0.00025	CcSEcCtD
Theophylline—Haematuria—Epirubicin—hematologic cancer	2.73e-05	0.000248	CcSEcCtD
Theophylline—Dizziness—Ifosfamide—hematologic cancer	2.73e-05	0.000248	CcSEcCtD
Theophylline—Pruritus—Gemcitabine—hematologic cancer	2.7e-05	0.000246	CcSEcCtD
Theophylline—Nausea—Thiotepa—hematologic cancer	2.69e-05	0.000245	CcSEcCtD
Theophylline—Anaphylactic shock—Dexamethasone—hematologic cancer	2.68e-05	0.000244	CcSEcCtD
Theophylline—Anaphylactic shock—Betamethasone—hematologic cancer	2.68e-05	0.000244	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—hematologic cancer	2.68e-05	0.000244	CcSEcCtD
Theophylline—Diarrhoea—Irinotecan—hematologic cancer	2.68e-05	0.000244	CcSEcCtD
Theophylline—Diarrhoea—Mitoxantrone—hematologic cancer	2.68e-05	0.000244	CcSEcCtD
Theophylline—Vomiting—Carmustine—hematologic cancer	2.68e-05	0.000244	CcSEcCtD
Theophylline—Insomnia—Triamcinolone—hematologic cancer	2.67e-05	0.000243	CcSEcCtD
Theophylline—Gastrointestinal pain—Etoposide—hematologic cancer	2.66e-05	0.000242	CcSEcCtD
Theophylline—Infection—Dexamethasone—hematologic cancer	2.66e-05	0.000242	CcSEcCtD
Theophylline—Infection—Betamethasone—hematologic cancer	2.66e-05	0.000242	CcSEcCtD
Theophylline—Dizziness—Vincristine—hematologic cancer	2.66e-05	0.000242	CcSEcCtD
Theophylline—Rash—Carmustine—hematologic cancer	2.66e-05	0.000242	CcSEcCtD
Theophylline—Dermatitis—Carmustine—hematologic cancer	2.65e-05	0.000241	CcSEcCtD
Theophylline—Vomiting—Alitretinoin—hematologic cancer	2.65e-05	0.000241	CcSEcCtD
Theophylline—Headache—Carmustine—hematologic cancer	2.64e-05	0.00024	CcSEcCtD
Theophylline—Shock—Dexamethasone—hematologic cancer	2.64e-05	0.00024	CcSEcCtD
Theophylline—Shock—Betamethasone—hematologic cancer	2.64e-05	0.00024	CcSEcCtD
Theophylline—Rash—Alitretinoin—hematologic cancer	2.63e-05	0.000239	CcSEcCtD
Theophylline—Nervous system disorder—Dexamethasone—hematologic cancer	2.63e-05	0.000239	CcSEcCtD
Theophylline—Nervous system disorder—Betamethasone—hematologic cancer	2.63e-05	0.000239	CcSEcCtD
Theophylline—Agitation—Prednisone—hematologic cancer	2.63e-05	0.000239	CcSEcCtD
Theophylline—Dermatitis—Alitretinoin—hematologic cancer	2.63e-05	0.000239	CcSEcCtD
Theophylline—Vomiting—Ifosfamide—hematologic cancer	2.62e-05	0.000239	CcSEcCtD
Theophylline—Hypersensitivity—Cisplatin—hematologic cancer	2.62e-05	0.000238	CcSEcCtD
Theophylline—Tachycardia—Betamethasone—hematologic cancer	2.62e-05	0.000238	CcSEcCtD
Theophylline—Tachycardia—Dexamethasone—hematologic cancer	2.62e-05	0.000238	CcSEcCtD
Theophylline—Headache—Alitretinoin—hematologic cancer	2.61e-05	0.000238	CcSEcCtD
Theophylline—Diarrhoea—Gemcitabine—hematologic cancer	2.61e-05	0.000237	CcSEcCtD
Theophylline—Nausea—Thalidomide—hematologic cancer	2.61e-05	0.000237	CcSEcCtD
Theophylline—Rash—Ifosfamide—hematologic cancer	2.6e-05	0.000237	CcSEcCtD
Theophylline—Dermatitis—Ifosfamide—hematologic cancer	2.6e-05	0.000236	CcSEcCtD
Theophylline—Dizziness—Irinotecan—hematologic cancer	2.59e-05	0.000236	CcSEcCtD
Theophylline—Urticaria—Etoposide—hematologic cancer	2.59e-05	0.000235	CcSEcCtD
Theophylline—Abdominal pain—Etoposide—hematologic cancer	2.58e-05	0.000234	CcSEcCtD
Theophylline—Body temperature increased—Etoposide—hematologic cancer	2.58e-05	0.000234	CcSEcCtD
Theophylline—Vomiting—Vincristine—hematologic cancer	2.56e-05	0.000233	CcSEcCtD
Theophylline—Anorexia—Dexamethasone—hematologic cancer	2.56e-05	0.000233	CcSEcCtD
Theophylline—Anorexia—Betamethasone—hematologic cancer	2.56e-05	0.000233	CcSEcCtD
Theophylline—Urticaria—Prednisolone—hematologic cancer	2.55e-05	0.000232	CcSEcCtD
Theophylline—Rash—Vincristine—hematologic cancer	2.54e-05	0.000231	CcSEcCtD
Theophylline—Dermatitis—Vincristine—hematologic cancer	2.53e-05	0.00023	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—hematologic cancer	2.53e-05	0.00023	CcSEcCtD
Theophylline—Headache—Vincristine—hematologic cancer	2.52e-05	0.000229	CcSEcCtD
Theophylline—Hypotension—Dexamethasone—hematologic cancer	2.51e-05	0.000228	CcSEcCtD
Theophylline—Hypotension—Betamethasone—hematologic cancer	2.51e-05	0.000228	CcSEcCtD
Theophylline—Nausea—Carmustine—hematologic cancer	2.5e-05	0.000228	CcSEcCtD
Theophylline—Vomiting—Irinotecan—hematologic cancer	2.49e-05	0.000227	CcSEcCtD
Theophylline—Vomiting—Mitoxantrone—hematologic cancer	2.49e-05	0.000227	CcSEcCtD
Theophylline—Nausea—Alitretinoin—hematologic cancer	2.48e-05	0.000226	CcSEcCtD
Theophylline—Convulsion—Prednisone—hematologic cancer	2.48e-05	0.000226	CcSEcCtD
Theophylline—Rash—Irinotecan—hematologic cancer	2.47e-05	0.000225	CcSEcCtD
Theophylline—Rash—Mitoxantrone—hematologic cancer	2.47e-05	0.000225	CcSEcCtD
Theophylline—Dermatitis—Mitoxantrone—hematologic cancer	2.47e-05	0.000224	CcSEcCtD
Theophylline—Dermatitis—Irinotecan—hematologic cancer	2.47e-05	0.000224	CcSEcCtD
Theophylline—Headache—Mitoxantrone—hematologic cancer	2.45e-05	0.000223	CcSEcCtD
Theophylline—Headache—Irinotecan—hematologic cancer	2.45e-05	0.000223	CcSEcCtD
Theophylline—Nausea—Ifosfamide—hematologic cancer	2.45e-05	0.000223	CcSEcCtD
Theophylline—Diarrhoea—Cisplatin—hematologic cancer	2.43e-05	0.000221	CcSEcCtD
Theophylline—Anxiety—Prednisone—hematologic cancer	2.43e-05	0.000221	CcSEcCtD
Theophylline—Alopecia—Methotrexate—hematologic cancer	2.43e-05	0.000221	CcSEcCtD
Theophylline—Vomiting—Gemcitabine—hematologic cancer	2.43e-05	0.000221	CcSEcCtD
Theophylline—Insomnia—Dexamethasone—hematologic cancer	2.43e-05	0.000221	CcSEcCtD
Theophylline—Insomnia—Betamethasone—hematologic cancer	2.43e-05	0.000221	CcSEcCtD
Theophylline—Rash—Gemcitabine—hematologic cancer	2.41e-05	0.000219	CcSEcCtD
Theophylline—Dermatitis—Gemcitabine—hematologic cancer	2.4e-05	0.000219	CcSEcCtD
Theophylline—Hypersensitivity—Etoposide—hematologic cancer	2.4e-05	0.000218	CcSEcCtD
Theophylline—Headache—Gemcitabine—hematologic cancer	2.39e-05	0.000217	CcSEcCtD
Theophylline—Nausea—Vincristine—hematologic cancer	2.39e-05	0.000217	CcSEcCtD
Theophylline—Flushing—Epirubicin—hematologic cancer	2.39e-05	0.000217	CcSEcCtD
Theophylline—Hypersensitivity—Prednisolone—hematologic cancer	2.37e-05	0.000215	CcSEcCtD
Theophylline—Urticaria—Triamcinolone—hematologic cancer	2.35e-05	0.000214	CcSEcCtD
Theophylline—Body temperature increased—Triamcinolone—hematologic cancer	2.34e-05	0.000213	CcSEcCtD
Theophylline—Anaphylactic shock—Prednisone—hematologic cancer	2.34e-05	0.000212	CcSEcCtD
Theophylline—Decreased appetite—Dexamethasone—hematologic cancer	2.33e-05	0.000212	CcSEcCtD
Theophylline—Decreased appetite—Betamethasone—hematologic cancer	2.33e-05	0.000212	CcSEcCtD
Theophylline—Nausea—Mitoxantrone—hematologic cancer	2.33e-05	0.000212	CcSEcCtD
Theophylline—Nausea—Irinotecan—hematologic cancer	2.33e-05	0.000212	CcSEcCtD
Theophylline—Infection—Prednisone—hematologic cancer	2.32e-05	0.000211	CcSEcCtD
Theophylline—Pruritus—Etoposide—hematologic cancer	2.31e-05	0.00021	CcSEcCtD
Theophylline—Shock—Prednisone—hematologic cancer	2.3e-05	0.000209	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—hematologic cancer	2.3e-05	0.000209	CcSEcCtD
Theophylline—Nervous system disorder—Prednisone—hematologic cancer	2.29e-05	0.000208	CcSEcCtD
Theophylline—Tachycardia—Prednisone—hematologic cancer	2.28e-05	0.000207	CcSEcCtD
Theophylline—Alopecia—Epirubicin—hematologic cancer	2.27e-05	0.000207	CcSEcCtD
Theophylline—Nausea—Gemcitabine—hematologic cancer	2.27e-05	0.000206	CcSEcCtD
Theophylline—Vomiting—Cisplatin—hematologic cancer	2.26e-05	0.000206	CcSEcCtD
Theophylline—Rash—Cisplatin—hematologic cancer	2.24e-05	0.000204	CcSEcCtD
Theophylline—Dermatitis—Cisplatin—hematologic cancer	2.24e-05	0.000204	CcSEcCtD
Theophylline—Diarrhoea—Etoposide—hematologic cancer	2.23e-05	0.000203	CcSEcCtD
Theophylline—Anorexia—Prednisone—hematologic cancer	2.23e-05	0.000202	CcSEcCtD
Theophylline—Flushing—Doxorubicin—hematologic cancer	2.21e-05	0.000201	CcSEcCtD
Theophylline—Tension—Epirubicin—hematologic cancer	2.2e-05	0.0002	CcSEcCtD
Theophylline—Gastrointestinal pain—Betamethasone—hematologic cancer	2.19e-05	0.000199	CcSEcCtD
Theophylline—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.19e-05	0.000199	CcSEcCtD
Theophylline—Hypersensitivity—Triamcinolone—hematologic cancer	2.18e-05	0.000198	CcSEcCtD
Theophylline—Nervousness—Epirubicin—hematologic cancer	2.17e-05	0.000198	CcSEcCtD
Theophylline—Dizziness—Etoposide—hematologic cancer	2.15e-05	0.000196	CcSEcCtD
Theophylline—Urticaria—Betamethasone—hematologic cancer	2.13e-05	0.000194	CcSEcCtD
Theophylline—Urticaria—Dexamethasone—hematologic cancer	2.13e-05	0.000194	CcSEcCtD
Theophylline—Dizziness—Prednisolone—hematologic cancer	2.13e-05	0.000193	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—hematologic cancer	2.12e-05	0.000193	CcSEcCtD
Theophylline—Abdominal pain—Betamethasone—hematologic cancer	2.12e-05	0.000193	CcSEcCtD
Theophylline—Abdominal pain—Dexamethasone—hematologic cancer	2.12e-05	0.000193	CcSEcCtD
Theophylline—Body temperature increased—Dexamethasone—hematologic cancer	2.12e-05	0.000193	CcSEcCtD
Theophylline—Body temperature increased—Betamethasone—hematologic cancer	2.12e-05	0.000193	CcSEcCtD
Theophylline—Nausea—Cisplatin—hematologic cancer	2.11e-05	0.000192	CcSEcCtD
Theophylline—Insomnia—Prednisone—hematologic cancer	2.11e-05	0.000192	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—hematologic cancer	2.1e-05	0.000191	CcSEcCtD
Theophylline—Pruritus—Triamcinolone—hematologic cancer	2.09e-05	0.00019	CcSEcCtD
Theophylline—Convulsion—Methotrexate—hematologic cancer	2.07e-05	0.000188	CcSEcCtD
Theophylline—Vomiting—Etoposide—hematologic cancer	2.07e-05	0.000188	CcSEcCtD
Theophylline—Agitation—Epirubicin—hematologic cancer	2.06e-05	0.000187	CcSEcCtD
Theophylline—Rash—Etoposide—hematologic cancer	2.05e-05	0.000187	CcSEcCtD
Theophylline—Dermatitis—Etoposide—hematologic cancer	2.05e-05	0.000187	CcSEcCtD
Theophylline—Headache—Etoposide—hematologic cancer	2.04e-05	0.000186	CcSEcCtD
Theophylline—Tension—Doxorubicin—hematologic cancer	2.03e-05	0.000185	CcSEcCtD
Theophylline—Decreased appetite—Prednisone—hematologic cancer	2.03e-05	0.000185	CcSEcCtD
Theophylline—Rash—Prednisolone—hematologic cancer	2.03e-05	0.000184	CcSEcCtD
Theophylline—Dermatitis—Prednisolone—hematologic cancer	2.02e-05	0.000184	CcSEcCtD
Theophylline—Headache—Prednisolone—hematologic cancer	2.01e-05	0.000183	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—hematologic cancer	2.01e-05	0.000183	CcSEcCtD
Theophylline—Palpitations—Epirubicin—hematologic cancer	1.98e-05	0.00018	CcSEcCtD
Theophylline—Dizziness—Triamcinolone—hematologic cancer	1.95e-05	0.000178	CcSEcCtD
Theophylline—Anaphylactic shock—Methotrexate—hematologic cancer	1.95e-05	0.000178	CcSEcCtD
Theophylline—Convulsion—Epirubicin—hematologic cancer	1.94e-05	0.000176	CcSEcCtD
Theophylline—Infection—Methotrexate—hematologic cancer	1.94e-05	0.000176	CcSEcCtD
Theophylline—Nausea—Etoposide—hematologic cancer	1.94e-05	0.000176	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—hematologic cancer	1.91e-05	0.000174	CcSEcCtD
Theophylline—Gastrointestinal pain—Prednisone—hematologic cancer	1.91e-05	0.000174	CcSEcCtD
Theophylline—Nausea—Prednisolone—hematologic cancer	1.91e-05	0.000174	CcSEcCtD
Theophylline—Agitation—Doxorubicin—hematologic cancer	1.9e-05	0.000173	CcSEcCtD
Theophylline—Anxiety—Epirubicin—hematologic cancer	1.9e-05	0.000173	CcSEcCtD
Theophylline—Pruritus—Betamethasone—hematologic cancer	1.9e-05	0.000173	CcSEcCtD
Theophylline—Pruritus—Dexamethasone—hematologic cancer	1.9e-05	0.000173	CcSEcCtD
Theophylline—Vomiting—Triamcinolone—hematologic cancer	1.88e-05	0.000171	CcSEcCtD
Theophylline—Rash—Triamcinolone—hematologic cancer	1.86e-05	0.00017	CcSEcCtD
Theophylline—Dermatitis—Triamcinolone—hematologic cancer	1.86e-05	0.000169	CcSEcCtD
Theophylline—Anorexia—Methotrexate—hematologic cancer	1.86e-05	0.000169	CcSEcCtD
Theophylline—Urticaria—Prednisone—hematologic cancer	1.86e-05	0.000169	CcSEcCtD
Theophylline—Headache—Triamcinolone—hematologic cancer	1.85e-05	0.000168	CcSEcCtD
Theophylline—Abdominal pain—Prednisone—hematologic cancer	1.85e-05	0.000168	CcSEcCtD
Theophylline—Body temperature increased—Prednisone—hematologic cancer	1.85e-05	0.000168	CcSEcCtD
Theophylline—Diarrhoea—Dexamethasone—hematologic cancer	1.83e-05	0.000167	CcSEcCtD
Theophylline—Diarrhoea—Betamethasone—hematologic cancer	1.83e-05	0.000167	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—hematologic cancer	1.83e-05	0.000166	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—hematologic cancer	1.83e-05	0.000166	CcSEcCtD
Theophylline—Hypotension—Methotrexate—hematologic cancer	1.82e-05	0.000166	CcSEcCtD
Theophylline—Infection—Epirubicin—hematologic cancer	1.81e-05	0.000165	CcSEcCtD
Theophylline—Shock—Epirubicin—hematologic cancer	1.8e-05	0.000163	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—hematologic cancer	1.79e-05	0.000163	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—hematologic cancer	1.79e-05	0.000163	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—hematologic cancer	1.78e-05	0.000162	CcSEcCtD
Theophylline—Dizziness—Betamethasone—hematologic cancer	1.77e-05	0.000161	CcSEcCtD
Theophylline—Dizziness—Dexamethasone—hematologic cancer	1.77e-05	0.000161	CcSEcCtD
Theophylline—Insomnia—Methotrexate—hematologic cancer	1.77e-05	0.000161	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—hematologic cancer	1.76e-05	0.00016	CcSEcCtD
Theophylline—Nausea—Triamcinolone—hematologic cancer	1.76e-05	0.00016	CcSEcCtD
Theophylline—Anorexia—Epirubicin—hematologic cancer	1.74e-05	0.000158	CcSEcCtD
Theophylline—Hypersensitivity—Prednisone—hematologic cancer	1.72e-05	0.000157	CcSEcCtD
Theophylline—Hypotension—Epirubicin—hematologic cancer	1.71e-05	0.000155	CcSEcCtD
Theophylline—Vomiting—Betamethasone—hematologic cancer	1.7e-05	0.000155	CcSEcCtD
Theophylline—Vomiting—Dexamethasone—hematologic cancer	1.7e-05	0.000155	CcSEcCtD
Theophylline—Decreased appetite—Methotrexate—hematologic cancer	1.7e-05	0.000154	CcSEcCtD
Theophylline—Rash—Betamethasone—hematologic cancer	1.69e-05	0.000154	CcSEcCtD
Theophylline—Rash—Dexamethasone—hematologic cancer	1.69e-05	0.000154	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—hematologic cancer	1.69e-05	0.000154	CcSEcCtD
Theophylline—Dermatitis—Dexamethasone—hematologic cancer	1.69e-05	0.000154	CcSEcCtD
Theophylline—Dermatitis—Betamethasone—hematologic cancer	1.69e-05	0.000154	CcSEcCtD
Theophylline—Headache—Dexamethasone—hematologic cancer	1.68e-05	0.000153	CcSEcCtD
Theophylline—Headache—Betamethasone—hematologic cancer	1.68e-05	0.000153	CcSEcCtD
Theophylline—Infection—Doxorubicin—hematologic cancer	1.68e-05	0.000153	CcSEcCtD
Theophylline—Shock—Doxorubicin—hematologic cancer	1.66e-05	0.000151	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—hematologic cancer	1.66e-05	0.000151	CcSEcCtD
Theophylline—Pruritus—Prednisone—hematologic cancer	1.65e-05	0.00015	CcSEcCtD
Theophylline—Insomnia—Epirubicin—hematologic cancer	1.65e-05	0.00015	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—hematologic cancer	1.65e-05	0.00015	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—hematologic cancer	1.61e-05	0.000147	CcSEcCtD
Theophylline—Diarrhoea—Prednisone—hematologic cancer	1.6e-05	0.000145	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—hematologic cancer	1.6e-05	0.000145	CcSEcCtD
Theophylline—Nausea—Dexamethasone—hematologic cancer	1.59e-05	0.000145	CcSEcCtD
Theophylline—Nausea—Betamethasone—hematologic cancer	1.59e-05	0.000145	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—hematologic cancer	1.59e-05	0.000144	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—hematologic cancer	1.58e-05	0.000144	CcSEcCtD
Theophylline—Urticaria—Methotrexate—hematologic cancer	1.55e-05	0.000141	CcSEcCtD
Theophylline—Dizziness—Prednisone—hematologic cancer	1.54e-05	0.00014	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—hematologic cancer	1.54e-05	0.00014	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—hematologic cancer	1.54e-05	0.00014	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—hematologic cancer	1.53e-05	0.000139	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—hematologic cancer	1.49e-05	0.000136	CcSEcCtD
Theophylline—Vomiting—Prednisone—hematologic cancer	1.48e-05	0.000135	CcSEcCtD
Theophylline—Rash—Prednisone—hematologic cancer	1.47e-05	0.000134	CcSEcCtD
Theophylline—Dermatitis—Prednisone—hematologic cancer	1.47e-05	0.000134	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—hematologic cancer	1.47e-05	0.000134	CcSEcCtD
Theophylline—Headache—Prednisone—hematologic cancer	1.46e-05	0.000133	CcSEcCtD
Theophylline—Urticaria—Epirubicin—hematologic cancer	1.45e-05	0.000132	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—hematologic cancer	1.44e-05	0.000131	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—hematologic cancer	1.44e-05	0.000131	CcSEcCtD
Theophylline—Hypersensitivity—Methotrexate—hematologic cancer	1.44e-05	0.000131	CcSEcCtD
Theophylline—Nausea—Prednisone—hematologic cancer	1.39e-05	0.000126	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.38e-05	0.000126	CcSEcCtD
Theophylline—Pruritus—Methotrexate—hematologic cancer	1.38e-05	0.000126	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—hematologic cancer	1.35e-05	0.000122	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—hematologic cancer	1.34e-05	0.000122	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—hematologic cancer	1.34e-05	0.000122	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—hematologic cancer	1.34e-05	0.000122	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—hematologic cancer	1.34e-05	0.000121	CcSEcCtD
Theophylline—Pruritus—Epirubicin—hematologic cancer	1.29e-05	0.000118	CcSEcCtD
Theophylline—Dizziness—Methotrexate—hematologic cancer	1.29e-05	0.000117	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—hematologic cancer	1.25e-05	0.000114	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—hematologic cancer	1.25e-05	0.000113	CcSEcCtD
Theophylline—Vomiting—Methotrexate—hematologic cancer	1.24e-05	0.000113	CcSEcCtD
Theophylline—Rash—Methotrexate—hematologic cancer	1.23e-05	0.000112	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—hematologic cancer	1.23e-05	0.000112	CcSEcCtD
Theophylline—Headache—Methotrexate—hematologic cancer	1.22e-05	0.000111	CcSEcCtD
Theophylline—Dizziness—Epirubicin—hematologic cancer	1.21e-05	0.00011	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—hematologic cancer	1.2e-05	0.000109	CcSEcCtD
Theophylline—Vomiting—Epirubicin—hematologic cancer	1.16e-05	0.000106	CcSEcCtD
Theophylline—Nausea—Methotrexate—hematologic cancer	1.16e-05	0.000105	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—hematologic cancer	1.16e-05	0.000105	CcSEcCtD
Theophylline—Rash—Epirubicin—hematologic cancer	1.15e-05	0.000105	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—hematologic cancer	1.15e-05	0.000105	CcSEcCtD
Theophylline—Headache—Epirubicin—hematologic cancer	1.14e-05	0.000104	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—hematologic cancer	1.12e-05	0.000102	CcSEcCtD
Theophylline—Nausea—Epirubicin—hematologic cancer	1.08e-05	9.87e-05	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—hematologic cancer	1.07e-05	9.77e-05	CcSEcCtD
Theophylline—Rash—Doxorubicin—hematologic cancer	1.07e-05	9.69e-05	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—hematologic cancer	1.06e-05	9.68e-05	CcSEcCtD
Theophylline—Headache—Doxorubicin—hematologic cancer	1.06e-05	9.63e-05	CcSEcCtD
Theophylline—Nausea—Doxorubicin—hematologic cancer	1e-05	9.13e-05	CcSEcCtD
Theophylline—PDE4C—Signaling Pathways—HRAS—hematologic cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1B—hematologic cancer	1.28e-06	1.58e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—PIK3CA—hematologic cancer	1.28e-06	1.57e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CDKN1A—hematologic cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MYC—hematologic cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PTEN—hematologic cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PIK3CA—hematologic cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—AKT1—hematologic cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TGFB1—hematologic cancer	1.26e-06	1.56e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.26e-06	1.56e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—IDH1—hematologic cancer	1.26e-06	1.55e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CASP3—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MYC—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL2—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TGFB1—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTT1—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3R1—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GSTM1—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—NCOR1—hematologic cancer	1.25e-06	1.54e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL6—hematologic cancer	1.25e-06	1.53e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TXN—hematologic cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK8—hematologic cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.23e-06	1.51e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—hematologic cancer	1.23e-06	1.51e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PIK3CA—hematologic cancer	1.23e-06	1.51e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NQO1—hematologic cancer	1.22e-06	1.51e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CD44—hematologic cancer	1.22e-06	1.51e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—hematologic cancer	1.22e-06	1.51e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—hematologic cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—SDC1—hematologic cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—JUN—hematologic cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—hematologic cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.22e-06	1.5e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NQO1—hematologic cancer	1.21e-06	1.5e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CD44—hematologic cancer	1.21e-06	1.5e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EP300—hematologic cancer	1.21e-06	1.49e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PIK3CA—hematologic cancer	1.21e-06	1.49e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.19e-06	1.46e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—hematologic cancer	1.19e-06	1.46e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—hematologic cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTEN—hematologic cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SRC—hematologic cancer	1.17e-06	1.45e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—hematologic cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—hematologic cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—MTHFR—hematologic cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—hematologic cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYCS—hematologic cancer	1.16e-06	1.43e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—hematologic cancer	1.16e-06	1.43e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK8—hematologic cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CB—hematologic cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—hematologic cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—hematologic cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYCS—hematologic cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—hematologic cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.14e-06	1.4e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.14e-06	1.4e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—hematologic cancer	1.14e-06	1.4e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—hematologic cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—hematologic cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRAS—hematologic cancer	1.13e-06	1.39e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—hematologic cancer	1.13e-06	1.39e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EP300—hematologic cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—hematologic cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—hematologic cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—hematologic cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—hematologic cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—hematologic cancer	1.11e-06	1.37e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.11e-06	1.36e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—MTHFR—hematologic cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SRC—hematologic cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—hematologic cancer	1.09e-06	1.34e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK3—hematologic cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—hematologic cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—hematologic cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NUP98—hematologic cancer	1.07e-06	1.32e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—hematologic cancer	1.07e-06	1.32e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—hematologic cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—hematologic cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—hematologic cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—hematologic cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—hematologic cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRAS—hematologic cancer	1.05e-06	1.29e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFB1—hematologic cancer	1.05e-06	1.29e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CD44—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NQO1—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—hematologic cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—hematologic cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NUP214—hematologic cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—hematologic cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.02e-06	1.26e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—hematologic cancer	1.02e-06	1.25e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.02e-06	1.25e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTR—hematologic cancer	1.01e-06	1.25e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.01e-06	1.25e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.01e-06	1.25e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.01e-06	1.24e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK3—hematologic cancer	1.01e-06	1.24e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—hematologic cancer	1e-06	1.24e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—hematologic cancer	9.96e-07	1.23e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTEN—hematologic cancer	9.95e-07	1.23e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO2—hematologic cancer	9.93e-07	1.22e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—hematologic cancer	9.9e-07	1.22e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—hematologic cancer	9.86e-07	1.22e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—hematologic cancer	9.84e-07	1.21e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—hematologic cancer	9.82e-07	1.21e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYCS—hematologic cancer	9.82e-07	1.21e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.8e-07	1.21e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—hematologic cancer	9.79e-07	1.21e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFB1—hematologic cancer	9.76e-07	1.2e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	9.75e-07	1.2e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—hematologic cancer	9.73e-07	1.2e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.71e-07	1.2e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ABCB1—hematologic cancer	9.67e-07	1.19e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTT1—hematologic cancer	9.63e-07	1.19e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ABCB1—hematologic cancer	9.58e-07	1.18e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—hematologic cancer	9.53e-07	1.17e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—EP300—hematologic cancer	9.49e-07	1.17e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—hematologic cancer	9.42e-07	1.16e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SDC1—hematologic cancer	9.42e-07	1.16e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—hematologic cancer	9.39e-07	1.16e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTM1—hematologic cancer	9.38e-07	1.16e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NCOR1—hematologic cancer	9.38e-07	1.16e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTM1—hematologic cancer	9.3e-07	1.15e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NCOR1—hematologic cancer	9.3e-07	1.15e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—hematologic cancer	9.26e-07	1.14e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—hematologic cancer	9.13e-07	1.13e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CREBBP—hematologic cancer	9.1e-07	1.12e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—hematologic cancer	9.04e-07	1.11e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—hematologic cancer	8.94e-07	1.1e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.9e-07	1.1e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—hematologic cancer	8.79e-07	1.08e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.78e-07	1.08e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—hematologic cancer	8.69e-07	1.07e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTP1—hematologic cancer	8.65e-07	1.07e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—hematologic cancer	8.65e-07	1.07e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CD—hematologic cancer	8.63e-07	1.06e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CREBBP—hematologic cancer	8.58e-07	1.06e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—hematologic cancer	8.52e-07	1.05e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—hematologic cancer	8.49e-07	1.05e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.37e-07	1.03e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—hematologic cancer	8.31e-07	1.02e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—MTHFR—hematologic cancer	8.29e-07	1.02e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—hematologic cancer	8.27e-07	1.02e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—MTHFR—hematologic cancer	8.22e-07	1.01e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ABCB1—hematologic cancer	8.19e-07	1.01e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3R1—hematologic cancer	8.15e-07	1e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CD—hematologic cancer	8.14e-07	1e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—hematologic cancer	8.04e-07	9.9e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—hematologic cancer	8.03e-07	9.9e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CD44—hematologic cancer	8.01e-07	9.86e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NQO1—hematologic cancer	8.01e-07	9.86e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NCOR1—hematologic cancer	7.95e-07	9.8e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTM1—hematologic cancer	7.95e-07	9.8e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—hematologic cancer	7.91e-07	9.75e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CREBBP—hematologic cancer	7.87e-07	9.7e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—hematologic cancer	7.69e-07	9.47e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3R1—hematologic cancer	7.69e-07	9.47e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYCS—hematologic cancer	7.58e-07	9.33e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	7.53e-07	9.27e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CB—hematologic cancer	7.52e-07	9.27e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CD—hematologic cancer	7.46e-07	9.19e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—hematologic cancer	7.37e-07	9.08e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—hematologic cancer	7.36e-07	9.07e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—hematologic cancer	7.3e-07	9e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.25e-07	8.93e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CB—hematologic cancer	7.09e-07	8.74e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3R1—hematologic cancer	7.05e-07	8.68e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—MTHFR—hematologic cancer	7.03e-07	8.66e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—hematologic cancer	7.02e-07	8.65e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—hematologic cancer	6.97e-07	8.59e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—hematologic cancer	6.91e-07	8.51e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—hematologic cancer	6.79e-07	8.36e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTP1—hematologic cancer	6.68e-07	8.23e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CB—hematologic cancer	6.5e-07	8.01e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTEN—hematologic cancer	6.5e-07	8.01e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CREBBP—hematologic cancer	6.46e-07	7.96e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CREBBP—hematologic cancer	6.41e-07	7.89e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.32e-07	7.79e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—EP300—hematologic cancer	6.2e-07	7.64e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.19e-07	7.63e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.14e-07	7.56e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.14e-07	7.56e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTEN—hematologic cancer	6.13e-07	7.55e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CD—hematologic cancer	6.13e-07	7.55e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CD—hematologic cancer	6.07e-07	7.48e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—hematologic cancer	6.05e-07	7.45e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—hematologic cancer	6e-07	7.39e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—hematologic cancer	5.9e-07	7.27e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—EP300—hematologic cancer	5.85e-07	7.2e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3R1—hematologic cancer	5.78e-07	7.13e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—hematologic cancer	5.74e-07	7.07e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3R1—hematologic cancer	5.73e-07	7.07e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTEN—hematologic cancer	5.62e-07	6.93e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CREBBP—hematologic cancer	5.47e-07	6.74e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.42e-07	6.68e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—EP300—hematologic cancer	5.36e-07	6.6e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CB—hematologic cancer	5.34e-07	6.58e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CB—hematologic cancer	5.29e-07	6.52e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CD—hematologic cancer	5.19e-07	6.39e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—hematologic cancer	5.12e-07	6.31e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3R1—hematologic cancer	4.9e-07	6.04e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTEN—hematologic cancer	4.61e-07	5.69e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—hematologic cancer	4.59e-07	5.65e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTEN—hematologic cancer	4.57e-07	5.64e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.56e-07	5.61e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CB—hematologic cancer	4.52e-07	5.57e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—EP300—hematologic cancer	4.4e-07	5.42e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—EP300—hematologic cancer	4.36e-07	5.38e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—hematologic cancer	4.32e-07	5.33e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.22e-07	5.21e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.01e-07	4.94e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—hematologic cancer	3.96e-07	4.89e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—hematologic cancer	3.95e-07	4.87e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTEN—hematologic cancer	3.91e-07	4.82e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.78e-07	4.66e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—hematologic cancer	3.75e-07	4.62e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—EP300—hematologic cancer	3.73e-07	4.59e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—hematologic cancer	3.53e-07	4.35e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.49e-07	4.3e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—hematologic cancer	3.26e-07	4.01e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—hematologic cancer	3.24e-07	3.99e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—hematologic cancer	3.23e-07	3.98e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTEN—hematologic cancer	3.02e-07	3.72e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—EP300—hematologic cancer	2.88e-07	3.55e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.76e-07	3.4e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—hematologic cancer	2.66e-07	3.28e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—hematologic cancer	2.64e-07	3.25e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—hematologic cancer	2.25e-07	2.78e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.13e-07	2.62e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—hematologic cancer	1.74e-07	2.14e-06	CbGpPWpGaD
